United Therapeutics Corp NASDAQ:UTHR:

  • ACQUIRES THYMMUNE THERAPEUTICS

  • DEAL VALUED AT $140 MILLION CASH PLUS UP TO $160 MILLION IN EARN-OUTS BY 2031